Our meta-analysis confirmed that single dose of intravenous iron isomaltoside ferumoxytol and repeated doses of oral iron sucrose resulted in comparable Hb change, serum ferritin and transferrin saturation for the treatment of iron deficiency anemia. The gene discussed is GSTM1; the disease is Iron deficiency anemia.